Chong Kun Dang Pharmaceutical

185750.KO

58.42 USD

0.25

+0.43%

Overview

Last close

58.42 usd

Market cap

769.77M usd

52 week high

80.07 usd

52 week low

48.18 usd

Target price

78.89 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.3512

Price/Book Value

1.1972

Enterprise Value

809.58M usd

EV/Revenue

0.7226

EV/EBITDA

9.1845

Key financials

Revenue TTM

569.35M usd

Gross Profit TTM

226.03M usd

EBITDA TTM

65.99M usd

Earnings per Share

N/A usd

Dividend

0.33 usd

Total assets

1.25B usd

Net debt

98.28M usd

About

Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.

Symbol
185750.KO
Exchange
KO
Isin
KR7185750007
Country
South Korea
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Young-Joo Kim
Headquarter
Seoul
Web site
https://www.ckdpharm.com

Related indices

JAKOTA Mid and Small Cap 2000 Index

173.48 +0.82%

Related news

September 18

Chong Kun Dang Partners With Novo Nordisk on Wegovy Sales in Korea

November 18

JAKOTA Stocks on November 17, 2023